Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker ACN
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Oct 14, 2026 | ACN Accenture plc | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 1, 2026 | ACN Accenture plc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 10, 2026 | ACN Accenture plc | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 23, 2026 | ACN Accenture plc | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 18, 2026 | ACN Accenture plc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 24, 2026 | ACN Accenture plc | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Apr 24, 2026 | ACN Accenture plc | 1.02 Termination of a Material Definitive Agreement | 8-K | 8-K ↗ |
| Apr 24, 2026 | ACN Accenture plc | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Mar 19, 2026 | ACN Accenture plc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 28, 2026 | ACN Accenture plc | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Jan 28, 2026 | ACN Accenture plc | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Dec 18, 2025 | ACN Accenture plc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Sep 25, 2025 | ACN Accenture plc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 17, 2025 | ACN Accenture plc | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K/A | 8-K ↗ |
| Jun 20, 2025 | ACN Accenture plc | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 20, 2025 | ACN Accenture plc | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Jun 20, 2025 | ACN Accenture plc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 20, 2025 | ACN Accenture plc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 13, 2025 | ACN Accenture plc | 8.01 Other Events | 8-K | 8-K ↗ |
| Feb 6, 2025 | ACN Accenture plc | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Dec 19, 2024 | ACN Accenture plc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 2, 2024 | ACN Accenture plc | 8.01 Other Events | 8-K | 8-K ↗ |
22 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:51 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances